Intramolecular Heck Reactions for the Synthesis of the Novel Antibiotic Mensacarcin
FULL PAPER
less solid; R = 0.4. IR (KBr): ν = 3560 cm–1, 2838, 1572. UV
3.87 (s, 3 H, OCH3), 4.03 (d, J = 11.2 Hz, 1 H, CH2Ph), 4.55 (d, J
˜
f
(CH3CN): λmax (lg ε) = 203.5 nm (4.6397), 292.0 (3.5932). 1H NMR = 11.2 Hz, 1 H, CH2Ph), 5.16 (dd, J = 12.4, 1.6 Hz, 1 H, 2ЈЈ-H),
(300 MHz, CDCl3): δ = 1.20–1.24 (m, 1 H, 5Ј-H), 1.29–1.37 (m, 1
H, 5Ј-H), 2.60 (s, 3 H, CH3), 3.52 (s, 3 H, OCH3), 3.74 (s, 3 H,
5.41 (dd, J = 12.4, 1.6 Hz, 1 H, 2ЈЈ-H), 6.25 (s, 1 H, 1Ј-H), 6.89 (d,
J = 8.2 Hz, 1 H, Ar-H), 7.10–7.25 (m, 3 H, Ar-H), 7.25–7.37 (m,
OCH3), 3.62–3.82 (m, 2 H, 4Ј-H/6Ј-H), 4.01–4.21 (m, 2 H, 4Ј-H/ 4 H, Ar-H), 7.66 (d, J = 9.2 Hz, 1 H, 1ЈЈ-H), 10.16 (s, 1 H, CHO)
6Ј-H), 4.41 (d, J = 12.0 Hz, 1 H, CH2Ph), 4.81 (d, J = 12.0 Hz, 1
H, CH2Ph), 5.15 (dd, J = 12.7, 1.6 Hz, 1 H, 2ЈЈ-H), 5.21 (dd, J =
12.7, 1.6 Hz, 1 H, 2ЈЈ-H), 5.45 (d, J = 7.2 Hz, 1 H, 1Ј-H), 5.93 (s,
1 H, 2Ј-H), 6.54 (d, J = 9.2 Hz, 1 H, 1ЈЈ-H), 6.64 (d, J = 8.2 Hz, 1
H, Ar-H), 6.95–7.09 (m, 3 H, Ar-H), 7.25–7.37 (m, 4 H, Ar-H)
ppm. 13C NMR (75.5 MHz, CDCl3): δ = 14.1, 55.3, 55.8, 59.2,
65.0, 80.4, 109.7, 118.6, 119.7, 124.2, 127.6, 128.6, 128.9, 129.1,
129.5, 129.9, 130.1, 130.2, 130.4, 136.4, 136.6, 137.8, 141.3, 152.3,
158.5, 158.2, 194.1 ppm. MS (EI, 70 eV): m/z (%) = 512.2 (38),
510.2 (42) [M]+, 433.1 (12) [M – Br]+. C27H27BrO5 (511.40).
ppm. 13C NMR (75.5 MHz, CDCl3): δ = 12.5, 14.1, 20.9, 25.8, HRMS: calcd. 510.1042; found 510.1042.
55.5, 55.8, 60.3, 67.4, 67.8, 99.1, 110.4, 111.4, 116.7, 119.9, 127.1,
6,11,12-Trimethoxy-2,2,5-trimethyl-7-methylene-7,12-dihydro-4H-
127.6, 127.8, 127.9, 128.2, 128.3, 128.4, 130.6, 133.5, 135.2, 137.6,
138.6, 148.6, 154.6, 157.4 ppm. MS (EI, 70 eV): m/z (%) = 556.1
(5), 554.1 (4) [M]+, 465.1 (43), 463.1 (42) [M – C7H7]+, 417.1 (11),
415.1 (10). C29H31BrO6 (555.46) HRMS: calcd. 554.1304; found
554.1304.
1,3-dioxabenzo[a]anthracene (rac-3). Procedure I: A magnetically
stirred solution of rac-2 (70 mg, 0.15 mmol) and nBu4NOAc
(46 mg, 0.15 mmol), in a degassed mixture of DMF/CH3CN/H2O
(2 mL of a 5:5:1 solution) at 60 °C was treated in one portion with
trans-{di(μ-acetato)-bis[ortho-(di-ortho-tolylphosphanyl)benzyl]di-
palladium(ii)} (4; 14 mg, 0.015 mmol). The resulting suspension
was heated to 120 °C for 4 h with stirring. The ensuing brown mix-
ture was cooled, diluted with diethyl ether (20 mL) and washed
with water (3×3 mL). The organic layer was dried (MgSO4), fil-
tered and concentrated under reduced pressure to afford a crude
brown solid. Subjection of this material to flash chromatography
(19:1 pentane/EtOAc) and concentration of the appropriate frac-
tions afforded the dihydroanthracene rac-3 (14 mg, 0.004 mmol,
24%) as a yellow solid along with starting material rac-2 (40 mg,
0.086 mmol, 57%). Rf = 0.2. UV/Vis: λmax (lg ε) = 201.5 (4.4756),
2-{(2-Benzyloxy-4-bromo-5-methoxy)-(3RS)-[methoxy-(2-methoxy-
6-vinylphenyl)methyl]-6-methylphenyl}-1,3-dioxane (rac-13): A mag-
netically stirred solution of diphenylcarbinol 12 (150 mg,
0.27 mmol) in THF (5 mL) was treated in one portion with KH
(22 mg, 0.54 mmol) at 0 °C. Stirring was continued for 40 min be-
fore the reaction mixture was treated dropwise with MeI (34 μL,
0.54 mmol). The ensuing solution was warmed to 20 °C and stirred
for a further 1 h before being treated with water (2 mL) and ex-
tracted with diethyl ether (3×5 mL). The combined organic frac-
tions were dried (MgSO4), filtered and concentrated under reduced
pressure to afford a colourless solid. Subjection of this material to
flash chromatography (19:1 pentane/EtOAc) and concentration of
the appropriate fractions afforded methyl ether 13 (148 mg,
290.5 (4.5398), 306.0 (3.5456) nm. IR (KBr): ν = 2929, 1456 cm–1.
˜
1H NMR (300 MHz, CDCl3): δ = 1.57 (s, 3 H, CH3), 1.61 (s, 3 H,
CH3), 2.11 (s, 3 H, CH3), 3.30 (s, 3 H, OCH3), 3.57 (s, 3 H, OCH3),
9.92 (s, 3 H, OCH3), 4.77 (s, 2 H, 4-H), 5.95 (d, J = 1.2 Hz, 1 H,
1Ј-H), 6.16 (s, 1 H, 12-H), 6.34 (d, J = 1.2 Hz, 1 H, 1Ј-H), 6.85–
6.89 (m, 1 H, Ar-H), 7.26–7.30 (m, 2 H, Ar-H) ppm. 13C NMR
(75.5 MHz, CDCl3): δ = 10.7, 24.5, 25.0, 55.7, 56.3, 59.7, 60.2, 64.0,
98.9, 109.5, 116.6, 117.2, 117.8, 122.2, 123.4, 127.0, 128.8, 129.2,
137.9, 140.8, 145.1, 148.9, 157.0 ppm. MS (EI, 70 eV): m/z (%) =
382 (32) [M+], 324 (100) [M – C3H6O]+, 293 (86) [M – C3H6O –
CH3O]+, 278 (65) [M – C3H6O – CH3O – CH3]+, 265 (29). HRMS:
calcd. for C23H26O5: 382.1780; found 382.1780. Procedure II:
Cy2NMe (12.5 μL, 59.3 μmol) in degassed dioxane (0.5 mL) and
P(tBu)3 (5.2 μL, 2.58 μmol of a 0.5 m solution in hexane) were
added, in a glovebox, to a magnetically stirred mixture of [Pd2-
(dba)3] (1.18 mg, 1.29 μmol) and rac-2 (20 mg, 43.0 μmol) at 20 °C.
The resulting suspension was heated to 120 °C for 5 h with stirring.
Work up was performed as described previously. Flash chromatog-
raphy (19:1 pentane/EtOAc) of the crude product afforded dihy-
droanthracene rac-3 (15.5 mg, 40.5 μmol, 94%) as a yellow solid
along with starting material rac-2 (1.1 mg, 2.4 μmol, 5 %). Pro-
0.26 mmol, 91 %) as a colourless oil; R = 0.2. IR (KBr): ν =
˜
f
3543 cm–1, 2812, 1589. UV (CH3CN): λmax (lg ε) = 209.0 nm
(4.7395), 294.5 (3.4654). 1H NMR (300 MHz, CDCl3): δ = 1.20–
1.24 (m, 1 H, 5Ј-H), 1.29–1.37 (m, 1 H, 5Ј-H), 2.60 (s, 3 H, CH3),
3.32 (s, 3 H, OCH3), 3.59 (s, 3 H, OCH3), 3.78 (s, 3 H, OCH3),
3.62–3.82 (m, 2 H, 4Ј-H/6Ј-H), 4.01- 4.21 (m, 2 H, 4Ј-H/6Ј-H), 4.41
(d, J = 12.4 Hz, 1 H, CH2Ph), 4.81 (d, J = 12.4 Hz, 1 H, CH2Ph),
5.15 (dd, J = 12.4, 1.6 Hz, 1 H, 2ЈЈ-H), 5.21 (dd, J = 12.4, 1.6 Hz,
1 H, 2ЈЈ-H), 5.74 (s, 1 H, 2Ј-H), 6.25 (s, 1 H, 1Ј-H) 6.54 (d, J =
9.2 Hz, 1 H, 1ЈЈ-H), 6.64 (d, J = 8.2 Hz, 1 H, Ar-H), 6.95–7.09 (m,
3 H, Ar-H), 7.25–7.37 (m, 4 H, Ar-H) ppm. 13C NMR (75.5 MHz,
CDCl3): δ = 13.7, 25.7, 55.4, 55.8, 57.4, 60.0, 67.62, 67.64, 80.2,
80.79, 80.80, 98.8, 109.6, 113.4, 120.8, 126.1, 126.2, 127.1, 127.6,
127.9, 130.6, 131.2, 132.6, 133.6, 137.9, 138.6, 139.9, 152.8, 153.1,
157.2 ppm. MS (EI, 70 eV): m/z (%) = 570.3 (20), 568.2 (19) [M]+,
479.2 (30), 477.2 (28), [M – CH2Ph]+, 447.2 (25), 445.2 (26), 91
(100). C30H33BrO6 (569.48) HRMS: calcd. 568.1461; found
568.1461.
2-Benzyloxy-4-bromo-5-methoxy-(3RS)-[methoxy-(2-methoxy-6-vi- cedure III: [Pd2(dba)3] (1.45 mg, 1.62 μmol) and HP(tBu)3BF4
nylphenyl)methyl]-6-methylbenzaldehyde (rac-6): A magnetically
stirred solution of acetal 13 (100 mg, 0.18 mmol) in a water/acetone
mixture (2.5:5 mL) was treated in one portion with a few crystals
of pyridinium p-toluenesulfonate at 20 °C. The resulting suspension
was heated at reflux for 12 h before being extracted with diethyl
(0.94 mg, 3.23 μmol) were transferred into a flask containing a
magnetic stirrer bar, which was then evacuated and refilled with
argon. A solution of rac-2 (25 mg, 53.9 μmol) and Cy2NMe
(12.5 μL, 59.3 μmol) in degassed dioxane (0.5 mL) was then added
in one portion at 20 °C. The resulting suspension was heated to
ether (3 ×15 mL). The combined organic fractions were washed 120 °C for 5 h with stirring. Work up was performed as described
with brine (1×2 mL), dried (MgSO4), filtered and concentrated un-
der reduced pressure to afford a crude solid. Subjection of this
material to flash chromatography (19:1 pentane/EtOAc) and con-
centration of the appropriate fractions afforded the corresponding
aldehyde 6 (65 mg, 0.13 mmol, 71%) as a colourless solid; Rf = 0.3.
previously. Flash chromatography (19:1 pentane/EtOAc) of the
crude product afforded dihydroanthracene rac-3 (18.8 mg,
49.3 μmol, 92%) as a yellow solid along with starting material rac-
2 (1.5 mg, 3.2 μmol, 6 %). Procedure IV: A magnetically stirred
solution of rac-2 (25 mg, 53.9 μmol), nBu4NOAc (29.5 mg,
107.8 μmol) and K2CO3 (14.9 mg, 107.8 μmol) in degassed DMF
IR (KBr): ν = 2941 cm–1, 1710, 1597. UV (CH CN): λ
(lg ε) =
˜
3
max
1
205.0 nm (4.6429), 292.0 (4.0995). H NMR (300 MHz, CDCl3): δ (0.5 mL) at 20 °C was treated with Pd(OAc)2 (1.21 mg, 5.39 μmol).
= 2.63 (s, 3 H, CH3), 3.34 (s, 3 H, OCH3), 3.56 (s, 3 H, OCH3), The resulting suspension was heated to 90 °C for 5 h with stirring.
Eur. J. Org. Chem. 2005, 1752–1759
© 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
1757